All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck

NCT04433169 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma of the Head and Neck

Interventions

DRUG: All-trans Retinoic Acid
DRUG: VEGFR inhibitor
DRUG: Chemotherapy

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University